Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Marra

Showing results (11-20 of 105) with videos related to

Pageof 11
Sort By:
Journal of Biomechanical Engineering|February 4, 2021
A Methodology to Evaluate the Effects of Kinematic Measurement Uncertainties on Knee Ligament Properties Estimated From Laxity MeasurementsMichael Skipper Andersen, Christine Mary Dzialo, Marco Antonio Marra, et al.
Expert Review of Anticancer Therapy|August 27, 2019
What therapies are on the horizon for HER2 positive breast cancer?Giulia Viale, Stefania Morganti, Emanuela Ferraro, et al.
Breast Cancer Research and Treatment|February 6, 2022
Refining risk stratification in HR-positive/HER2-negative early breast cancer: how to select patients for treatment escalation?Stefania Morganti, Antonio Marra, Edoardo Crimini, et al.
The Oncologist|September 4, 2023
Predicting Response to Antibody Drug Conjugates: A Focus on Antigens' TargetabilityLiliana Ascione, Edoardo Crimini, Dario Trapani, et al.
Breast Cancer Research and Treatment|January 8, 2025
Oral selective estrogen receptor degraders for breast cancer treatment: focus on pharmacological differencesRoberta Scafetta, Paola Zagami, Marzia Del Re, et al.
The Oncologist|August 14, 2020
Pretreatment Blood Parameters Predict Efficacy from Immunotherapy Agents in Early Phase Clinical TrialsCarmen Criscitiello, Antonio Marra, Stefania Morganti, et al.
Journal for Immunotherapy of Cancer|April 3, 2020
Master protocols in immuno-oncology: do novel drugs deserve novel designs?Luca Mazzarella, Stefania Morganti, Antonio Marra, et al.
European Journal of Cancer (Oxford, England : 1990)|September 2, 2021
Clinical outcomes of patients with metastatic breast cancer enrolled in phase I clinical trialsCarmen Criscitiello, Antonio Marra, Stefania Morganti, et al.
Cancer Treatment Reviews|June 29, 2026
Treatment of breast cancer brain metastases in the era of novel drugsJulian David Etessami, Giovanni Dalla Via, Emanuela Ferraro, et al.
Clinical Medicine Insights. Oncology|June 19, 2024
Use of Antibody-Drug Conjugates in the Early Setting of Breast CancerChrysanthi Koukoutzeli, Dario Trapani, Liliana Ascione, et al.
Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
Journal of Biomechanical Engineering|February 4, 2021
A Methodology to Evaluate the Effects of Kinematic Measurement Uncertainties on Knee Ligament Properties Estimated From Laxity MeasurementsMichael Skipper Andersen, Christine Mary Dzialo, Marco Antonio Marra, et al.
Expert Review of Anticancer Therapy|August 27, 2019
What therapies are on the horizon for HER2 positive breast cancer?Giulia Viale, Stefania Morganti, Emanuela Ferraro, et al.
Breast Cancer Research and Treatment|February 6, 2022
Refining risk stratification in HR-positive/HER2-negative early breast cancer: how to select patients for treatment escalation?Stefania Morganti, Antonio Marra, Edoardo Crimini, et al.
The Oncologist|September 4, 2023
Predicting Response to Antibody Drug Conjugates: A Focus on Antigens' TargetabilityLiliana Ascione, Edoardo Crimini, Dario Trapani, et al.
Breast Cancer Research and Treatment|January 8, 2025
Oral selective estrogen receptor degraders for breast cancer treatment: focus on pharmacological differencesRoberta Scafetta, Paola Zagami, Marzia Del Re, et al.
The Oncologist|August 14, 2020
Pretreatment Blood Parameters Predict Efficacy from Immunotherapy Agents in Early Phase Clinical TrialsCarmen Criscitiello, Antonio Marra, Stefania Morganti, et al.
Journal for Immunotherapy of Cancer|April 3, 2020
Master protocols in immuno-oncology: do novel drugs deserve novel designs?Luca Mazzarella, Stefania Morganti, Antonio Marra, et al.
European Journal of Cancer (Oxford, England : 1990)|September 2, 2021
Clinical outcomes of patients with metastatic breast cancer enrolled in phase I clinical trialsCarmen Criscitiello, Antonio Marra, Stefania Morganti, et al.
Cancer Treatment Reviews|June 29, 2026
Treatment of breast cancer brain metastases in the era of novel drugsJulian David Etessami, Giovanni Dalla Via, Emanuela Ferraro, et al.
Clinical Medicine Insights. Oncology|June 19, 2024
Use of Antibody-Drug Conjugates in the Early Setting of Breast CancerChrysanthi Koukoutzeli, Dario Trapani, Liliana Ascione, et al.
Pageof 11